Connect with us

Hi, what are you looking for?

Jewish Business News

Business

British BTG acquires Israeli Galil Medical for $110 million

Israel’s Galil Medical is a leader of cryoablation products for the treatment and palliative care of kidney and other cancers.

visual-ice-Galil Medical

 

British specialist healthcare company BTG has announced that it has entered into an agreement to acquire Galil Medical, a global leader in delivering innovative cryotherapy solutions for kidney and other cancers. The deal is said to be worth up to $110 million.

Galil Medical owns, manufactures and sells a portfolio of cryoablation systems and needles including Visual-ICE — a minimally invasive, easy-to-use system to precisely destroy solid tumor cancers of the kidney, lung, bone, liver and prostate.

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at office@jewishbusinessnews.com.
Thank you.

“This bolt-on acquisition builds on our leadership in Interventional Oncology, expanding our portfolio of minimally invasive therapies with the leading technology in the cryoablation of kidney cancer. It also offers significant pipeline opportunities, including lung and bone metastases if regulatory approvals are granted, ” said Louise Makin, BTG’s CEO.

In the US, Galil Medical’s products are indicated for the treatment and palliative care of kidney and other cancers, in addition to a number of other uses, including in urology. Galil Medical is presently conducting two clinical studies, both nearing completion, that could lead to US regulatory clearance for use in lung metastases and bone metastases.

“In addition to enhancing our offering to interventional radiologists, Galil Medical provides access to other specialist physicians that may in future include pulmonary specialists, complementing our existing PneumRx and EKOS businesses. Longer term, we are excited by the opportunity to explore the use of our locoregional radiation and cryoablation therapies alongside other developing technologies, ” said Makin.

BTG said in a press release that it will acquire Galil Medical for an initial cash consideration of $84.5m and up to $25.5m in future regulatory and commercial milestone payments.

Galil Medical has company offices in Minnesota, US and Yokneam, Israel.

Newsletter



Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Entertainment

The Movie The Professional is what made Natalie Portman a Lolita.

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.